Technology News Ethics, Regulation, and Responsible Use

AI scribes: Efficiency for whom?

March 12, 2026 By Kathryn Wighton 3 min read
Share Share via Email Share on Facebook Share on LinkedIn Share on Twitter

Clinical Report: AI Scribes in Healthcare—Efficiency and Ethical Challenges

Overview

AI scribes are increasingly used in US healthcare to reduce documentation burden, yet their adoption outpaces empirical validation. Concerns include inaccuracies, ethical issues, and regulatory gaps that may impact patient safety and trust.

Background

AI scribes utilize automated speech recognition and large language models to transcribe clinical encounters into draft medical notes. They are promoted to enhance workflow efficiency, physician well-being, and patient-centered care. However, systematic errors such as hallucinations and attribution mistakes can persist if clinicians do not thoroughly review notes. Additionally, AI scribes struggle to capture nuanced human communication, raising concerns about bias and documentation quality.

Data Highlights

The article highlights several key issues without presenting numerical data, focusing on qualitative concerns such as hallucinated content, over-capture of sensitive information, and privacy risks associated with cloud storage and third-party transcription review.

Key Findings

  • AI scribes often produce inaccuracies including hallucinated content, false inferences, and attribution errors that can compromise clinical safety and trust.
  • They fail to capture paralinguistic and pragmatic communication elements, which is particularly problematic in pediatrics, psychiatry, and patients with nonnormative speech.
  • Over-capture of sensitive information, such as immigration status, may lead to adverse impacts outweighing benefits.
  • Privacy concerns arise from cloud-based storage and third-party access to encounter recordings, with inadequate patient consent processes.
  • AI scribes are marketed as administrative tools and largely exempt from medical device regulation despite producing clinical documentation.
  • Calls for ex ante regulatory approval, standardized performance metrics, and post-deployment quality assurance are emphasized to ensure safety and efficacy.

Clinical Implications

Clinicians should remain vigilant in reviewing AI-generated notes to correct inaccuracies and avoid potential safety risks. Awareness of ethical and privacy concerns is essential, especially regarding sensitive information and patient consent. Healthcare systems should advocate for regulatory oversight and quality assurance to ensure AI scribes meet clinical standards.

Conclusion

While AI scribes offer potential efficiency benefits, unresolved clinical, ethical, and regulatory challenges necessitate cautious implementation and rigorous evaluation to safeguard patient care and trust.

References

  1. Francis et al. 2024 -- AI scribes: Efficiency for whom?

AACE Endocrine AI is published by Conexiant under a license arrangement with the American Association of Clinical Endocrinology, Inc. (AACE®). The ideas and opinions expressed in AACE Endocrine AI do not necessarily reflect those of Conexiant or AACE. For more information, see Policies.

Related Content